Ho Maykin Insider Trading Activity (AGIO)

Summary

Updated Jul 16, 2026

Ho Maykin has filed 4 SEC Form 4 filings across 4 companies in the last 90 days.

Role	Director
Notability	20/100

Recent Transactions

Date	Ticker	Company	Code	Shares	Price
2026-06-23	AGIO	AGIOS PHARMACEUTICALS, INC.	M — Option exercise	2.8K	$0.00
2026-06-04	BMRN	BIOMARIN PHARMACEUTICAL INC	A — Grant or award	7.5K	$0.00
2025-05-20	BMRN	BIOMARIN PHARMACEUTICAL INC	A — Grant or award	6.7K	$0.00

Companies — Last 90 Days

AGIOS PHARMACEUTICALS, INC. (AGIO) — 1 filings, last 2026-06-23
KYNTRA BIO, INC. (KYNB) — 1 filings, last 2026-06-17
BIOMARIN PHARMACEUTICAL INC (BMRN) — 1 filings, last 2026-06-04
Neumora Therapeutics, Inc. (NMRA) — 1 filings, last 2026-05-29

Frequently Asked Questions

Who is Ho Maykin?

Ho Maykin is a corporate insider — currently tracked as Director of AGIOS PHARMACEUTICALS, INC. (AGIO). InsiderAlpha tracks every SEC Form 4 filing in real time.

How many SEC Form 4 filings has Ho Maykin submitted recently?

4 primary Form 4 filings in the last 90 days, covering 4 companies.

Where can I see all of Ho Maykin's SEC filings?

All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.

Ho Maykin — SEC Form 4 Insider Trading Activity